Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$3.38
+2.58%
Mkt Cap $309.52M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 9, 2026 | — | — | — | -$0.10 | -$0.06 | +40.00% | — | — |
| Q4 2025 Nov 25, 2025 | — | — | — | -$0.13 | -$0.11 | +15.38% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.13 | -$0.16 | -23.08% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.16 | -$0.13 | +18.75% | — | — |
| Q1 2025 Feb 12, 2025 | — | — | — | -$0.17 | -$0.14 | +17.65% | — | — |
| Q4 2024 Dec 23, 2024 | — | — | — | -$0.17 | -$0.14 | +17.65% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$0.15 | -$0.14 | +6.67% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.13 | -$0.13 | +0.00% | — | — |
| Q1 2024 Feb 7, 2024 | — | — | — | -$0.15 | -$0.11 | +26.67% | — | — |
| Q4 2023 Nov 27, 2023 | — | — | — | -$0.16 | -$0.12 | +25.00% | — | — |
| Q3 2023 Aug 8, 2023 | — | — | — | -$0.17 | -$0.14 | +17.65% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.18 | -$0.17 | +5.56% | — | — |
| Q1 2023 Feb 7, 2023 | — | — | — | -$0.20 | -$0.17 | +15.00% | — | — |
| Q4 2022 Nov 28, 2022 | — | — | — | -$0.16 | -$0.18 | -12.50% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.15 | -$0.16 | -6.67% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.16 | -$0.14 | +12.50% | — | — |
| Q1 2022 Feb 9, 2022 | — | — | — | -$0.16 | -$0.14 | +12.50% | — | — |
| Q4 2021 Nov 24, 2021 | — | — | — | -$0.13 | -$0.15 | -15.38% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.13 | -$0.14 | -7.69% | — | — |
| Q2 2021 May 13, 2021 | — | — | — | -$0.12 | -$0.12 | +0.00% | — | — |